Advisory Committee on Immunization Practices recommends PCV15 for children younger than 19 years
Hispanic adults face barriers accessing care for peripheral artery disease
16 September 2022Largest study to date explores the use of telemedicine in child neurology
16 September 2022Advisory Committee on Immunization Practices recommends PCV15 for children younger than 19 years
The 15-valent pneumococcal conjugate vaccine (PCV15) can be used for children aged younger than 19 years, according to recommendations issued by the Advisory Committee on Immunization Practices and published in the Sept. 16 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
